Vanta Bioscience Limited (BOM:540729)
19.60
0.00 (0.00%)
At close: Sep 7, 2026
Vanta Bioscience Revenue
In the fiscal year ending March 31, 2026, Vanta Bioscience had annual revenue of 18.16M INR, down -7.49%. Vanta Bioscience had revenue of 15.15M in the half year ending March 31, 2026, a decrease of -56.94%.
Revenue
18.16M
Revenue Growth
-7.49%
P/S Ratio
6.81
Revenue / Employee
n/a
Employees
36
Market Cap
123.72M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 18.16M | -1.47M | -7.49% |
| Mar 31, 2025 | 19.64M | -77.59M | -79.80% |
| Mar 31, 2024 | 97.23M | 34.47M | 54.92% |
| Mar 31, 2023 | 62.76M | -37.42M | -37.36% |
| Mar 31, 2022 | 100.18M | -331.32K | -0.33% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BLT Logistics | 562.21M |
| Varyaa Creations | 349.69M |
| Neopolitan Pizza and Foods | 296.35M |
| Beryl Drugs | 213.23M |
| Mish Designs | 83.65M |
| Zodiac Ventures | 39.08M |
| BIL Vyapar | 17.37M |
| GCM Securities | 6.69M |